The Choice of Regimens Based on Bortezomib for Patients with Newly Diagnosed Multiple Myeloma

INTRODUCTION: Bortezomib has significantly improved multiple myeloma (MM) response rates, but strategies for choosing bortezomib-based regimens for initial MM therapy are not standardized. Here, we describe four bortezomib-based therapies in Chinese MM patients to determine the optimal chemotherapeu...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: He, Jingsong, Yang, Li, Han, Xiaoyan, Zheng, Gaofeng, Zheng, Weiyan, Wei, Guoqing, Wu, Wenjun, Ye, Xiujin, Shi, Jimin, Xie, Wanzhuo, Li, Li, Zhang, Jie, Huang, Weijia, Zhao, Yi, Huang, He, Zhang, Xuejin, Fu, Jiaping, Cai, Zhen
Formato: Artigo
Idioma:Inglês
Publicado: Public Library of Science 2014
Assuntos:
Research Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4053437/
https://ncbi.nlm.nih.gov/pubmed/24918626
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0099174
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares